BIIB vs IESC · P/E 21, rev $9.89B vs P/E 38, rev $3.37B
Biogen Inc (BIIB) versus IES Holdings Inc (IESC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
IES Holdings Inc (IESC) is a engineering & construction company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported IESC revenue for 2025-09-30 was $3.37B. Net income was $311.8M. IESC currently screens at market cap $14.36B and trailing P/E 38.5.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. IESC currently screens at market cap $14.36B and trailing P/E 38.5.
Not investment advice. Open the BIIB and IESC stock pages for the full models.
Not investment advice.